Inter Parfums (IPAR) Q1 2025 Earnings Call May 06, 2025 11:00 AM ET Company Participants Karin Daly - Investor RelationsJean Madar - Chairman, CEO & Co-FounderMichel Atwood - CFOAshley Helgans - Senior Vice PresidentHamed Khorsand - Principal Conference Call Participants Susan Anderson - Managing Director & Senior AnalystKorinne Wolfmeyer - Vice President & Senior Equity Research Analyst - Beauty and WellnessLuca Codagnone - Analyst Operator Greetings, and welcome to the Interperform's First Quarter twenty ...

Inter Parfums (IPAR) Q1 2025 Earnings Call May 06, 2025 11:00 AM ET Speaker0 Greetings, and welcome to the Interperform's First Quarter twenty twenty five Conference Call and Webcast. At this time, participants are in a listen only mode. As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to your host, Karen Daley, Vice President at The Equity Group and Interpoliform's Investor Relations representative. Please go ahead, Karen. Speaker1 Thank you, Kevin. Joining us on ...

Core Insights - Interparfums, Inc. reported a 5% increase in net sales for Q1 2025, reaching $339 million compared to $324 million in Q1 2024, reaffirming its sales and earnings guidance for 2025 [1][2][15] Financial Performance - Net sales for Q1 2025 were $339 million, a 5% increase from $324 million in Q1 2024 [2] - Gross margin improved to 63.7% from 62.5%, reflecting a 120 basis point increase [2][8] - Operating income rose by 10% to $75 million, with an operating margin of 22.2%, up from 21.0% [2][12] - Net income attributable to Interparfums, Inc. was $42 million, a 4% increase from $41 million in the previous year [2][28] - Diluted earnings per share (EPS) increased by 4% to $1.32 from $1.27 [2][28] Market Performance - Organic sales growth, excluding foreign exchange impacts and the Dunhill license discontinuation, was 7% [4] - North America and Western Europe saw sales increases of 14% and 1%, respectively, while Eastern Europe experienced a significant rebound with a 46% increase [5] - Asia/Pacific sales declined by 3%, and Central and South America saw a 10% decline, attributed to high prior year bases [5] Strategic Initiatives - The company renewed its partnership with Coach for an additional five years, extending the license until June 30, 2031 [6] - Interparfums is expanding its portfolio with the launch of the Solférino collection and acquisitions of Off-White and Annick Goutal, set for commercialization in 2026 [7] Financial Position - As of March 31, 2025, the company had $172 million in cash and cash equivalents, with working capital of $605 million [13] - SG&A expenses as a percentage of net sales were 41.6%, reflecting a slight increase due to higher advertising and promotional spending [9][11] - The company invested $52 million in A&P initiatives, representing 15.2% of net sales, a 7% increase from the prior year [11] Guidance - Interparfums reaffirms its 2025 guidance of net sales of $1.51 billion and earnings per diluted share of $5.35, both reflecting a 4% increase [15]

Inter Parfums, Inc. (IPAR) is likely to register a bottom-line decline when it reports first-quarter 2025 earnings on May 5. The Zacks Consensus Estimate for quarterly earnings has remained unchanged in the past 30 days at $1.13 per share, indicating an 11% decrease from $1.27 per share reported in the year-ago quarter. IPAR has a trailing four-quarter negative earnings surprise of 1%, on average. (Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.)Things to Know Ahead of IPAR’s Q1 Ea ...

Core Viewpoint - International Flavors & Fragrances Inc. (IFF) is expected to report a decline in sales and earnings for the first quarter of 2025, with a consensus estimate of $2.83 billion in sales, reflecting a 2.2% decrease year-over-year, and earnings per share estimated at $1.12, indicating a 0.9% dip from the previous year [1][2]. Financial Estimates - The consensus estimate for IFF's sales is $2.83 billion, down 2.2% from the prior year [1]. - The earnings estimate is $1.12 per share, which has increased by 2.7% over the past 60 days but shows a year-over-year decline of 0.9% [2]. - The earnings estimates for upcoming quarters are as follows: Q2 at $1.17, F1 at $4.20, and F2 at $4.54 [2]. Earnings Surprise History - IFF has beaten the Zacks Consensus Estimates in three of the last four quarters, with an average surprise of 17.9% [3][4]. Earnings ESP and Zacks Rank - IFF has an Earnings ESP of +1.05%, indicating a potential earnings beat [5]. - The company currently holds a Zacks Rank of 3, suggesting a hold position [6]. Performance Factors - IFF is experiencing volume growth across its business segments, which is expected to positively impact sales performance [7]. - The company is facing high raw material costs and additional expenses related to labor, shipping, and cleaning, which may negatively affect margins despite cost reduction efforts [8]. Segment Projections - The Nourish segment is projected to see a 3.6% decline in sales to $1.44 billion, with operating EBITDA expected to fall 2.1% to $211 million [9]. - The Scent segment's sales are estimated to decrease by 6% to $606 million, with operating EBITDA projected to decline 15.9% to $132 million [10]. - The Health & Biosciences segment is expected to report sales of $532 million, reflecting a slight increase of 0.2%, with operating EBITDA anticipated to rise 1.7% to $162 million [11]. Recent Developments - IFF completed the divestiture of its Pharma Solutions business to Roquette on May 1, 2025, which is expected to help the company achieve its target net debt to credit-adjusted EBITDA ratio of below 3.0X [12]. Stock Performance - Over the past year, IFF shares have decreased by 8%, contrasting with a 0.4% growth in the industry [13].

Core Insights - Analysts expect International Flavors (IFF) to report quarterly earnings of $1.12 per share, reflecting a year-over-year decline of 0.9% and revenues of $2.83 billion, down 2.2% from the previous year [1] Earnings Projections - Revisions to earnings projections are crucial for predicting investor behavior, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock performance [2] Key Metrics Estimates - Analysts project 'Net Sales- Nourish' to reach $1.45 billion, indicating a decline of 2.8% from the prior-year quarter [4] - The consensus estimate for 'Net Sales- Scent' is $609.74 million, reflecting a decrease of 5.5% year-over-year [4] - 'Net Sales- Pharma Solutions' is expected to be $233.97 million, showing a year-over-year increase of 3.1% [4] - 'Net Sales- Health & Biosciences' is forecasted at $532.05 million, indicating a slight increase of 0.2% from the previous year [5] Adjusted Operating EBITDA Estimates - 'Adjusted Operating EBITDA- Nourish' is projected to be $216.88 million, compared to $216 million in the same quarter last year [5] - 'Adjusted Operating EBITDA- Pharma Solutions' is expected to be $45.50 million, slightly down from $46 million year-over-year [6] - 'Adjusted Operating EBITDA- Scent' is estimated at $140.59 million, down from $157 million in the previous year [6] - 'Adjusted Operating EBITDA- Health & Biosciences' is projected to reach $159.94 million, compared to $159 million in the same quarter last year [7] Stock Performance - Over the past month, IFF shares have recorded a return of -0.2%, compared to a -0.7% change in the Zacks S&P 500 composite, indicating that IFF is likely to perform in line with the overall market [8]

Reaffirms FY2025 Guidance2025 First Quarter Conference Call Scheduled for May 6, 2025 NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced that for the three months ended March 31, 2025, net sales rose to $339 million, up 5% from $324 million in the first quarter of 2024. Net Sales ($ in millions)Three Months EndedMarch 31, 20252024% ChangeTotal Interparfums, Inc.$339< ...

Company Overview - WoodWick® Candles is a leader in home fragrance and part of the Newell Brands portfolio, known for its luxurious candle offerings since 2006 [5][7] - The company focuses on combining refined designs with nature-inspired fragrances, utilizing patented Pluswick® technology for a unique sensory experience [5][6] Product Launch - WoodWick® has introduced the Precious Metals Collection, a new line of candles inspired by Earth's rarest elements, featuring a metallic aesthetic and rich, multi-layered scents [1][2] - The collection includes eight fragrances, each reflecting the essence of precious metals such as gold, silver, and bronze, designed in elegant hourglass jars [4][5] Fragrance Details - The fragrances in the Precious Metals Collection include: - Sparkling Pomelo: Pink pepper, juicy lychee, and sparkling aldehydes [5] - Marine Amber: Blue sea salt, cedarwood, and pearl crystals [5] - Volcanic Orris: Pear, orris, and sandalwood [5] - Shimmering Spice: Saffron, bronzed leather, and smoked woods [5] - Rosa D'Oro: Damask rose, warm oud, and ambery labdanum [5] - Candescent Coast: Marine notes, white teak, and moss [5] - Melanite Mist: Aldehydes and rain on rock moss [5] - Cypress Ore: Lavender and blonde woods [5] Availability - The Precious Metals Collection is available for purchase at WoodWick.com and Yankee Candle stores for $24.99, with Amazon availability expected in late 2025 [4]